Impact of Delayed Initiation of Non-Invasive Ventilation for Respiratory Distress in Outborn Late-Preterm and Term Neonates

doi:10.21203/rs.3.rs-787747/v1

The frequency of non-invasive ventilation (NIV) use increased in neonates of all gestational ages with respiratory distress (RD). However, the impact of delayed initiation of NIV support in outborn neonates remains poor understood. The aim of the present study was to identify the impact of delayed initiation of NIV in outborn late-preterm and term neonates.

The medical records of 277 infants (gestational age of ≥ 35 weeks) who were received NIV as primary respiratory therapy <24 h of age between 2016 and 2020 were retrospectively reviewed. Among the 190 outborn neonates, the factors associated with respiratory adverse outcomes were investigated. Infants with RD divided into two groups, mild (FiO₂ ≤0.3) and moderate-to-severe RD group (FiO₂ >0.3), depending on initial oxygen requirement under NIV support.

Median time to start of NIV support at tertiary center was 3.5 (2.2–5.0) h. Male sex (odds ratio [OR], 2.9; 95% CI, 1.1–7.7), high oxygen requirement (FiO₂ >0.3) (OR, 4.8; 95% CI, 1.5–15.3), and respiratory distress syndrome (OR, 10.4; 95% CI, 3.9–27.8) were the significant factors associated with adverse outcomes. Subgroup analysis revealed that in the moderate-to-severe RD group, delayed initiation of NIV (≥3 h) was significantly associated with pulmonary air leakage (p=0.033).

Conclusions: Our study shows that outborn neonates with moderate-to-severe RD who were treated with delayed NIV were associated with an increased likelihood of pulmonary air leakage. Additional prospective studies are needed to establish the optimal timing and methods of NIV support for outborn late-preterm and term infants.

Pediatrics

Respiratory distress syndrome

Outborn

Newborn

Continuous Positive Airway Pressure

Non-invasive ventilation for respiratory support is widely utilized in neonates of all gestational ages.
Little is known about the impact of delayed initiation of non-invasive ventilation in outborn late-preterm and term neonates.

What is new

Male sex, high oxygen requirement (FiO₂ >0.3), and respiratory distress syndrome were the significant factors associated with adverse outcomes.
Outborn late-preterm and term neonates with high oxygen requirement who were treated with delayed non-invasive ventilation were associated with an increased likelihood of pulmonary air leakage.

Respiratory distress (RD) is one of the most frequent causes of admission to the neonatal intensive care unit (NICU) in term and preterm infants [1, 2]. Among infants admitted to the NICU, 15% of term infants and 29% of late-preterm infants develop significant respiratory morbidity. The most common respiratory morbidities are transient tachypnea of the newborn (TTN) and respiratory distress syndrome (RDS) [3]. Respiratory signs and/or requirement of oxygen typically present within the first hours of life, often immediately after delivery [3, 4].

Current neonatal resuscitation program (NRP) guidelines in the delivery room (DR) recommend continuous positive airway pressure (CPAP) as a corrective measure for all spontaneously breathing infants who present with labored breathing or persistent cyanosis [5, 6]. Hence, the frequency of CPAP use increased in late-preterm and term infants with RD within the first hours of life [7]. Various modes of non-invasive ventilation (NIV) (e.g., humidified high flow nasal cannula [HHFNC], nasal intermittent positive pressure ventilation [NIPPV], biphasic positive airway pressure [BiPAP]) are used as primary respiratory support together with CPAP, depending on the severity of manifestation [8, 9]

Despite this practical change, most infants who would have benefitted from NIV are born in community hospitals that do not offer this therapy. Alternatively, these infants receive supplemental oxygen via oxygen hood or nasal cannula while waiting for clinical improvement [10, 11]. Consequently, they receive high concentrations of inspired oxygen without sufficient distending pressure for a significant length of time. There is some evidence that early application of continuous distending pressure has a clinical benefit over delayed application in very preterm infants [12–14]. Unfortunately, data on the impact of delayed NIV in outborn late-preterm and term infants is scarce. Furthermore, its early use in these infants with mild RD is controversial due to concern for air leakage (e.g., pneumothorax) [15–17].

We conducted this study to assess the factors associated with adverse respiratory outcomes in outborn neonates born at ≥35 +0 weeks of gestation, who received NIV as primary respiratory therapy. We hypothesized that delayed initiation of NIV leads to adverse outcomes that vary according to the severity of the underlying disease.

We retrospectively reviewed the medical records of 1,709 neonates at ≥35⁺⁰ weeks of gestation who were hospitalized in the tertiary referral NICU of Korea University Ansan Hospital between January 2016 and December 2020. Our center is a regional hospital with level III NICU staff and nursing staff experienced in NIV use. During the 5-year period, there were 526 inborn neonates and 1,183 outborn neonates admitted to the NICU. This study was approved by the Institutional Research Ethics Committee of the Korea University Ansan Hospital (2021AS0193). Patient consent was waived due to retrospective study design.

Inclusion and exclusion criteria

The enrollment criteria were as follows: (1) neonates with RD but breathing spontaneously and received respiratory support, and (2) gestational age ≥35⁺⁰ weeks. We excluded patients with major congenital/chromosomal anomalies, suspected birth asphyxia, meconium-stained amniotic fluid, spontaneous pneumothorax, suspected pneumonia or sepsis, idiopathic persistent pulmonary hypertension (PPHN), non-pulmonary issues, those intubated in the DR and immediately placed on mechanical ventilation, and those who received primary respiratory therapy at ≥24 h of age.

Perinatal factors and definitions

Perinatal data were collected from the discharge summary report and confirmed by a detailed chart review. The collected information included maternal complications, gestational age, birth weight, size for gestational age, sex, mode of delivery, Apgar scores, the need for resuscitation or surfactant replacement therapy, presence of air leakage requiring thoracentesis, ventilatory support (presence, duration, modes, and type; invasive or noninvasive), duration of oxygen therapy, and days of NICU stay.

Data on symptom onset time, method of oxygen administration, and time to initiation of NIV therapy, which was defined as the time (in hours) between symptom onset and the initiation of NIV at the referred hospital, were collected from the neonatal transport summary.

TTN was diagnosed in the presence of RD with onset within 6 h after birth, defined as respiratory rate >60 breaths/min, grunting, nasal flaring, and intercostal, subcostal, and/or suprasternal retractions. Radiographic features of TTN included bilateral alveolar and interstitial edema, prominent pulmonary vascular pattern with increased perihilar markings, hyperinflated lungs, and/or fluid in the interlobar fissure. RDS was diagnosed based on the presence of at least two of the following symptoms: the need for supplemental oxygen, tachypnea, intercostal retraction, and grunting, with exclusion of other causes of RD. Radiographic features of RDS included low lung volumes and air bronchograms with diffuse, bilateral, and ground glass fields prior to surfactant treatment.

Neonates with RD were divided into two groups depending on their initial oxygen requirement with any NIV modalities; neonates in the mild RD group received a fraction of inspired oxygen (FiO₂) ≤30, while infants in the moderate-to-severe RD group received a FiO₂>30.

Respiratory support techniques

Once admitted to the NICU, the neonates were provided primary treatment in the form of four possible NIV devices: nasal CPAP, synchronized nasal intermittent positive pressure ventilation (sNIPPV), BiPAP, and HHFNC. The choice of whether and when to use NIV was at the discretion of the medical team, with no specific unit guideline on the choice of one strategy over another.

CPAP, BiPAP, and sNIPPV modes were delivered using Infant Flow SiPAP (Carefusion, USA) and Medin CNO (Medin Medical Innovations GmbH). To ensure that blood gas analysis results were within the normal range, infants on nasal CPAP received a positive end-expiratory pressure (PEEP) of 5 cm H₂O, which was adjusted to 4–7 cm H₂O, depending on the infant’s respiratory condition. Infants on BiPAP received a baseline PEEP of 5 cm H₂O, a high PEEP of 8 cm H₂O, and a respiratory rate of 30/min with an initial inspiratory time (Ti) of 0.5 s. The baseline PEEP was adjusted to 4–7 cm H₂O, and high PEEP was adjusted to 7–10 cm H₂O. Flow-sNIPPV was delivered with the following parameters: Ti, 0.3–0.35 s; peak inspiratory pressure (PIP), 8–12 cm H₂O; PEEP, 4–6 cm H₂O; back-up rate, 40 bpm. FiO₂ was adjusted in each device until a SpO₂ of 88%–94% was maintained.

HHFNC support was delivered using the Optiflow System (Fisher & Paykel Optiflow System, Healthcare, Auckland, New Zealand), with short binasal prongs. Infants received gas flow of 5 L/min initially, which was adjusted to 3–7 L/min, according to their condition.

Outcomes

Adverse outcomes were defined as mechanical ventilation therapy or the incidence of pulmonary air leakage. The latter was defined as pneumothorax or pneumomediastinum with RD that occurred during hospitalization, as diagnosed with chest radiography.

Statistical analysis

All data analyses were performed using SPSS 20.0 for Windows (SPSS Inc., Chicago, IL, USA). Continuous variables were analysed using the t-test and Mann–Whitney U test for normal and skewed distributions, respectively. Proportions were tested using chi-squared and Fisher's exact tests; statistical significance was set at p <0.05. The significant variables identified in the univariate analysis were further assessed using a multivariable logistic regression analysis. Data are presented as mean ± standard deviation (SD), median and range, or rate.

Out of the 1,709 neonates at ≥35⁺⁰ weeks of gestation who underwent hospitalization between January 2016 and December 2020, 502 late-preterm and term neonates with RD required respiratory support. Once the differential diagnoses were excluded, 277 neonates remained; this was further divided into inborn (n = 87) and outborn (n = 190) patients, with the latter serving as the subjects of this study (Figure 1).

The demographic and clinical data of the patients are presented in Table 1. The mean gestational age and birth weight of the patients were 37.9 ± 1.5 weeks and 3,228 ± 486 grams, respectively. Seventy-two percent (n = 135) of the neonates showed symptoms of RD shortly after birth and 65.3% (n = 124) required oxygen supplementation at DR. None of the outborn neonates received CPAP in the DR. The median time to start of NIV at our hospital was 3.5 (2.2–5.0) h, and the initial median SpO₂and FiO₂were 90% and 0.3, respectively. More cases of TTN (n = 116; 61.1%) were diagnosed than of RDS (n = 74; 38.9%). Outborn neonates had a greater history of mechanical ventilation (24.7% vs. 4.6%, p <0.001) and air leakage (17.4% vs. 1.1%, p <0.001) than inborn patients (Supplemental Table 1).

The following factors were significantly associated with adverse outcomes during hospitalization (Table 2): A younger gestational age (GA; 37.3 ± 1.0 vs. 38.1 ± 1.1 weeks, p = 0.003), lower birth weight (3 184 ± 384 vs. 3 251 ± 534 grams, p = 0.014), male sex (72.7% vs. 49.2%, p = 0.002), cesarean section (84.8% vs. 62.1%, p = 0.001), lower initial SpO₂ (83% [74.5–91.5] vs. 92% [87–97], p <0.001), higher initial FiO₂ (31.5 [26.5–36.5] vs. 25 [21–29], p <0.001), lower initial pH (7.20 [7.15–7.23] vs. 7.25 [7.21–7.32], p <0.001), higher CO₂ (61 [54–70] vs. 51 [44–60], p <0.001) and a primary diagnosis of RDS (83.3% vs. 15.3%, p <0.001). There was no significant difference in the time of NIV initiation in the NICU. Logistic regression analysis on the significant variables further revealed that the significant risk factors for adverse outcomes were male sex (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1–7.7), initial FiO₂ >30 (OR, 4.8; 95% CI, 1.5–15.3), and a primary diagnosis of RDS (OR, 10.4; 95% CI, 3.9–27.8) (Table 3).

Table 4 shows the clinical data for the mild and moderate-to-severe RD groups, further divided according to the time of NIV initiation (with 3 h as the cut-off). This allowed us to clarify the effects of underlying disease severity. In infants with moderate-to-severe RD, a significantly high incidence of air leakage occurred when the initiation of NIV therapy was delayed by >3 h, as compared to when NIV therapy was initiated earlier (35.7% vs. 5.9%, p = 0.033) (Figure 2). The median time to identify the pulmonary air leakage from initiation of first NIV was not significantly different between two groups (15.5 h [11.0–32.7] vs. 21.5 h [15.6–26.4]. p = 0.703) (Table 5). There was no significant difference in treatment of pulmonary air leakage (p = 1.000), 63.6% of neonates with mild RD and 54.5% of neonates with moderate-to-severe RD were treated with conservative managements such as observation or oxygen therapy (Supplemental Table 2).

To our knowledge, this is the first study to directly investigate the association between delayed initiation of NIV and pulmonary air leakage in outborn late-preterm and term neonates with significant oxygen requirement.

Non-invasive respiratory support (e.g., CPAP utilization) seems to be increasing, particularly in later gestational age categories, following the release of the NRP guidelines in 2011. Moreover, recent studies have shown that NIV, as compared to free flow O₂, may decrease the duration and severity of RD in late-preterm and term infants with TTN or RDS [9, 10, 18, 19]. In the present study, we found that out of the total number of neonates who were in RD and breathing spontaneously, 83% received CPAP or non‐invasive positive pressure ventilation (NPPV) as their primary respiratory support, whereas 17% received HHFNC after NICU arrival.

In agreement with previous studies, a low GA, male sex, birth by cesarean section, high oxygen requirement, and RDS were significant factors associated with adverse outcomes in our cohort [3, 20]. Additionally, our results showed that the frequency of air leakage was particularly high when there was a delay in respiratory support in cases of moderate-to-severe RD; while oxygen supplementation was initiated in all referred hospitals prior to NICU arrival, continuous pressure support was delayed due to the lack of appropriate devices. In a few small studies in the pre-surfactant era, delayed initiation of CPAP in infants with RDS was associated with significant development of pneumothorax [12, 21, 22]. The resulting difference in outcomes can be attributed to the alteration of the course of RDS among infants treated with continuous distending pressure early [21, 22]. Smithhart et al. showed in a large birth cohort study that the incidence of pneumothorax decreased with oxygen requirement among neonates who received early CPAP in the DR, suggesting that the risk of CPAP-induced pneumothorax is lower in lungs with underlying disease [15]. Similarly, a recent study by Hirata et al. reported that adverse prognosis of severe TTN was strongly associated with a longer time between birth and transport to a level III NICU [23]. This is consistent with the results of our study; we classified the severity of RD, allowing us to further clarify the effects of the primary disease.

The impact of outborn status on the greater risk of severe respiratory morbidities is unclear, given the inconsistencies in diagnosis and management [24–27]. In the present study, the incidence of air leakage in outborn neonates (17.4%) was higher than that in inborn neonates (1.1%). Additionally, RDS was the underlying primary lung disease in a large number of outborn neonates. Previous studies that utilized the national epidemiologic data of Korea reported that among term infants with RDS, the incidence of pneumothorax notably increased from 6.9% to 11.7% over 5 years. In contrast, there was no change in the incidence of pneumothorax in preterm infants with RDS [28]. The clinical characteristics of outborn and inborn neonates were also different, suggesting a different underlying mechanism of pneumothorax and/or resuscitation quality in the DR and during medical transport [26–29]. It is possible that the initiation of delayed CPAP in these neonates augment the levels of lung distending pressure towards the threshold for lung rupture; this is due to the fact that neonates born at term or moderate-to-late-preterm are capable of generating auto-positive end-expiratory pressure through grunting and struggling [25]. Careful monitoring and precise adjustment of modes of respiratory support for air leakage are needed in outborn neonates with moderate-to-severe RD, including those diagnosed with RDS. In addition, based on the findings of our study, we believe that early initiation of continuous distending pressure (e.g., CPAP) might lead to a marked reduction in adverse outcomes. Immediate application of non-invasive respiratory support, instead of oxygen supplementation, should be considered in late-preterm and term neonates who show apparent respiratory symptoms and significant oxygen requirement. Additional prospective studies are needed to establish the optimal timing and methods of primary respiratory support.

However, this study has several limitations—one of which is its retrospective design. The restriction of the study to neonates who were admitted to the NICU resulted in a small sample size. In the current study, antenatal steroids were not administered to the mothers of all outborn neonates; this is not in concordance with the by the American College of Obstetricians and Gynecologists (ACOG) guidelines in 2020 which recommend the administration of betamethasone for pregnant women who are at risk of having a late-preterm birth [30]. The indication for each NIV device was at the discretion of the attending neonatologist, which may have influenced the outcomes. Notably, there were no significant differences in the type of primary respiratory support between the inborn and outborn neonates, with or without adverse outcomes. Since the accessibility of outborn neonates with RD varies widely by center, our results may not be generalizable to other centers where the characteristics of patients differ from ours.

In conclusion, this study confirmed that outborn infants with moderate-to-severe RD who were treated with delayed non-invasive respiratory support were associated with an increased likelihood of pulmonary air leakage.

Funding

This research received no external funding.

Conflicts of interest

The authors declare no conflict of interest

Availability of data and material

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable

Authors’ Contributions

Eui Kyung Choi: Primary author, Data Collection, Data analysis, Manuscript writing.

Kyu Hee Park: Data Collection

Byung Min Choi: Drafting of the manuscript, Editing, Critical revision of the manuscript, Responsible for the overall content.

All authors provided contributions, have read and approved the final version.

Ethics approval

This study was approved by the Institutional Research Ethics Committee of the Korea University Ansan Hospital (2021AS0193).

Consent to participate

Patient consent was waived due to retrospective study design.

Consent for publication

Written informed consent for publication was obtained from all authors.

ACOG American College of Obstetricians and Gynecologists

BiPAP biphasic positive airway pressure

CPAP continuous positive airway pressure

DR delivery room

FiO₂fraction of inspired oxygen

HHFNC humidified high flow nasal cannula

NICU neonatal intensive care unit

NIPPV nasal intermittent positive pressure ventilation

NIV non-invasive ventilation

NPPV non‐invasive positive pressure ventilation

NRP neonatal resuscitation program

OR odds ratio

PEEP positive end-expiratory pressure

PIP peak inspiratory pressure

PPHN persistent pulmonary hypertension

RD respiratory distress

RDS respiratory distress syndrome

SD standard deviation

sNIPPV synchronized nasal intermittent positive pressure ventilation

Ti inspiratory time

TTN transient tachypnea of the newborn

Reuter S, Moser C, Baack M (2014) Respiratory distress in the newborn. Pediatr Rev 35:417–428. https://doi.org/10.1542/pir.35-10-417 quiz 429.
Qian L, Liu C, Zhuang W et al (2008) Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China. Pediatrics 121:e1115–e1124. https://doi.org/10.1542/peds.2006-2426
Consortium on Safe L, Hibbard JU, Wilkins I et al (2010) Respiratory morbidity in late preterm births. JAMA 304:419–425. https://doi.org/10.1001/jama.2010.1015
Pramanik AK, Rangaswamy N, Gates T (2015) Neonatal respiratory distress: a practical approach to its diagnosis and management. Pediatr Clin North Am 62:453–469. https://doi.org/10.1016/j.pcl.2014.11.008
Wyckoff MH, Aziz K, Escobedo MB, Kapadia VS, Kattwinkel J, Perlman JM, Simon WM, Weiner GM, Zaichkin JG (2015) Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 132:S543–S560. https://doi.org/10.1161/cir.0000000000000267
Aziz K, Lee CHC, Escobedo MB et al (2021) Part 5: Neonatal Resuscitation 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics 147 https://doi.org/10.1542/peds.2020-038505E
Spillane NT, Macalintal F, Nyirenda T, Golombek SG (2021) What happens to 35 week infants that receive delivery room continuous positive airway pressure? J Perinatol. https://doi.org/10.1038/s41372-020-00883-w
Moresco L, Romantsik O, Calevo MG, Bruschettini M (2020) Non-invasive respiratory support for the management of transient tachypnea of the newborn. Cochrane Database Syst Rev 4:Cd013231. https://doi.org/10.1002/14651858.CD013231.pub2
Cimino C, Saporito MAN, Vitaliti G, Pavone P, Mauceri L, Gitto E, Corsello G, Lubrano R, Falsaperla R (2020) N-BiPAP vs n-CPAP in term neonate with respiratory distress syndrome. Early Hum Dev 142:104965
Buckmaster AG, Arnolda G, Wright IM, Foster JP, Henderson-Smart DJ (2007) Continuous positive airway pressure therapy for infants with respiratory distress in non tertiary care centers: a randomized, controlled trial. Pediatrics 120:509–518. https://doi.org/10.1542/peds.2007-0775
Frey B, Shann F (2003) Oxygen administration in infants. Arch Dis Child Fetal Neonatal Ed 88:F84–F88. https://doi.org/10.1136/fn.88.2.f84
Ho JJ, Subramaniam P, Sivakaanthan A, Davis PG (2020) Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants. Cochrane Database Syst Rev 10:Cd002975. https://doi.org/10.1002/14651858.CD002975.pub2
Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY (2013) Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. Bmj 347:f5980. https://doi.org/10.1136/bmj.f5980
Miksch RM, Armbrust S, Pahnke J, Fusch C (2008) Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP. Eur J Pediatr 167:909–916. https://doi.org/10.1007/s00431-007-0646-1
Smithhart W, Wyckoff MH, Kapadia V, Jaleel M, Kakkilaya V, Brown LS, Nelson DB, Brion LP (2019) Delivery Room Continuous Positive Airway Pressure and Pneumothorax. Pediatrics 144 https://doi.org/10.1542/peds.2019-0756
Clevenger L, Britton JR (2017) Delivery room continuous positive airway pressure and early pneumothorax in term newborn infants. J Neonatal Perinatal Med 10:157–161. https://doi.org/10.3233/npm-171694
Hishikawa K, Goishi K, Fujiwara T, Kaneshige M, Ito Y, Sago H (2015) Pulmonary air leak associated with CPAP at term birth resuscitation. Arch Dis Child Fetal Neonatal Ed 100:F382–F387. https://doi.org/10.1136/archdischild-2014-307891
Osman AM, El-Farrash RA, Mohammed EH (2019) Early rescue Neopuff for infants with transient tachypnea of newborn: a randomized controlled trial. J Matern Fetal Neonatal Med 32:597–603. https://doi.org/10.1080/14767058.2017.1387531
Chiruvolu A, Claunch KM, Garcia AJ, Petrey B, Hammonds K, Mallett LH (2021) Effect of continuous positive airway pressure versus nasal cannula on late preterm and term infants with transient tachypnea of the newborn. J Perinatol. https://doi.org/10.1038/s41372-021-01068-9
Gulczyńska E, Szczapa T, Hożejowski R, Borszewska-Kornacka MK, Rutkowska M (2019) Fraction of Inspired Oxygen as a Predictor of CPAP Failure in Preterm Infants with Respiratory Distress Syndrome: A Prospective Multicenter Study. Neonatology 116:171–178. https://doi.org/10.1159/000499674
Hegyi T, Hiatt IM (1981) The effect of continuous positive airway pressure on the course of respiratory distress syndrome: the benefits on early initiation. Crit Care Med 9:38–41. https://doi.org/10.1097/00003246-198101000-00009
Allen LP, Reynolds ER, Rivers RP, Le Souëf PM, Wimberley PD (1977) Controlled trial of continuous positive airway pressure given by face mask for hyaline membrane disease. Arch Dis Child 52:373–378. https://doi.org/10.1136/adc.52.5.373
Hirata K, Nozaki M, Mochizuki N, Hirano S, Wada K (2019) Impact of Time to Neonatal Transport on Outcomes of Transient Tachypnea of the Newborn. Am J Perinatol 36:1090–1096. https://doi.org/10.1055/s-0038-1676490
Boo NY, Cheah IG, Malaysian National Neonatal R (2011) Risk factors associated with pneumothorax in Malaysian neonatal intensive care units. J Paediatr Child Health 47:183–190. https://doi.org/10.1111/j.1440-1754.2010.01944.x
Duong HH, Mirea L, Shah PS, Yang J, Lee SK, Sankaran K (2014) Pneumothorax in neonates: Trends, predictors and outcomes. J Neonatal Perinatal Med 7:29–38. https://doi.org/10.3233/npm-1473813
Trevisanuto D, Doglioni N, Ferrarese P, Vedovato S, Cosmi E, Zanardo V (2005) Neonatal pneumothorax: comparison between neonatal transfers and inborn infants. J Perinat Med 33:449–454. https://doi.org/10.1515/jpm.2005.079
Cornette L, Mulder A, Debeer A, Malfilâtre G, Rigo V, Cools F, Danhaive O (2021) Surfactant use in late preterm infants: a survey among Belgian neonatologists. Eur J Pediatr 180:885–892. https://doi.org/10.1007/s00431-020-03806-1
Shin JE, Yoon SJ, Lim J, Han J, Eun HS, Park MS, Park KI, Lee SM (2020) Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea. J Korean Med Sci 35:e253. https://doi.org/10.3346/jkms.2020.35.e253
Fang JL, Mara KC, Weaver AL, Clark RH, Carey WA (2020) Outcomes of outborn extremely preterm neonates admitted to a NICU with respiratory distress. Arch Dis Child Fetal Neonatal Ed 105:33–40. https://doi.org/10.1136/archdischild-2018-316244
Siegler Y, Weiner Z, Solt I (2020) ACOG Practice Bulletin No. 217: Prelabor Rupture of Membranes. Obstet Gynecol 136:1061. https://doi.org/10.1097/AOG.0000000000004142

Table 1. Demographic and clinical data of the outborn neonates with respiratory distress

Characteristics	Outborn (n = 190)
Gestational age, mean (SD), weeks	37.9 ±1.5
Birth weight, mean (SD), g	3,228 ± 486
Male, no (%)	109 (57.4%)
Small for gestational age, no (%)	3 (0.6%)
Large for gestational age, no (%)	29 (15.3%)
Apgar score, 1 min, median (IQR),	8 (8–9)
Apgar score, 5 min, median (IQR),	9 (9–10)
Cesarean section, no (%)	133/190 (70.0%)
Maternal hypertensive disorder, no (%)	6/190 (3.2%)
Diabetes mellitus, no (%)	19/190 (10.0%)
Antenatal steroid (complete), no (%)	0 /190 (0.0%)
Twin, no (%)	8/190 (4.2%)
Delivery room management
Flow Oxygen, no (%)	124/190 (65.3%)
CPAP, no (%)	0/190 (0.0)
PPV, no (%)	14/190 (7.4)
Symptom onset time, median (IQR), min	0 (0–60)
Time to respiratory support, median (IQR), hour	3.5 (2.2–5.0)
Initial SpO₂, median (IQR), %	91 (83–96)
Initial FiO₂, median (IQR), %	30 (25–30)
pH on admission, median (IQR)	7.23 (7.19–7.28)
capillary CO₂ on admission, median (IQR), mmHg	55.2 (46.0–63.0)
Body temperature on admission, median (IQR), ℃	36.6 (36.5–37.0)
Initial Therapy
HHFNC, no (%)	32/190 (16.8%)
CPAP or NPPV, no (%)	158/190 (83.2%)
Primary Diagnosis
TTN, no (%)	116/190 (61.1%)
RDS, no (%)	74/190 (38.9%)
Air leakage during hospitalization, no (%)	33/190 (17.4%)
MV during hospitalization, no (%)	47/190 (24.7%)
Respiratory support days, median (IQR), days	3.5 (2.8-5.0)
Mortality, no (%)	1/190 (0.5%)
Hospital stays, median (IQR), days	8 (6-10)

SD: standard deviation; IQR: interquartile range; CPAP: continuous positive airway pressure; PPV: positive pressure ventilation; SpO₂: saturation of partial pressure oxygen; FiO₂: fraction of inspired oxygen; CO₂:carbon dioxide; HHFNC: humidified high flow nasal cannula; NPPV: non‐invasive positive pressure ventilation; TTN: transient tachypnea of the newborn; RDS: respiratory distress syndrome; MV: mechanical ventilation

Table 2. Factors associated with adverse outcomes during hospitalization in outborn neonates

	No complication (n = 124)	Air leakage or mechanical ventilation during hospitalization (n = 66)	P
Gestational age, mean (SD), weeks	38.1 ± 1.1	37.3 ± 1.0	0.003
Birth weight, mean (SD), g	3,251 ± 534	3,184 ± 384	0.014
Male, no (%)	61/124 (49.2)	48/66 (72.7)	0.002
Cesarean section, no (%)	77/124 (62.1)	56/66 (84.8)	0.001
Small for gestational age, no (%)	3/124 (2.4)	0/66 (0)	0.553
Large for gestational age, no (%)	16/124 (15.3)	10/66 (15.2)	0.975
Maternal hypertensive disorder, no (%)	3/124 (2.4)	3/66 (4.5)	0.420
Diabetes mellitus, no (%)	12/124 (9.7)	7/66 (10.6)	0.839
Delivery room management
Flow Oxygen, no (%)	83/124 (66.9)	41/66 (62.1)	0.507
CPAP, no (%)	0/124 (0)	0/66 (0)
PPV, no (%)	8/124 (6.5)	6/66 (9.1)	0.507
Symptom onset time, median (IQR), min	0 (0–0)	0 (0–60)	0.315
Time to respiratory support, median (IQR), hour	3.5 (2.3–5.2)	4.0 (2.9–5.2)	0.437
Initial SpO₂, median (IQR), %	92 (87–97)	83 (74.5–91.5)	0.000
Initial FiO₂, median (IQR), %	25 (21–29)	31.5 (26.5–36.5)	0.000
Initial FiO₂ >30%, no (%)	12/124 (9.7)	33/66 (50.0)	0.000
pH on admission, median (IQR)	7.25 (7.21–7.32)	7.20 (7.15–7.23)	0.000
Capillary CO₂ on admission, median (IQR), mmHg	51 (44–60)	61 (54–70)	0.000
Body temperature on admission, median (IQR), ℃	36.6 (36.5–37.0)	36.6 (36.5–37.0)	0.635
Initial Therapy			0.299
HHFNC, no (%)	20/124 (16.1)	7/66 (10.6)
CPAP/NPPV, no (%)	104/124 (83.9)	59/66 (89.4)
Primary Diagnosis
TTN, no (%)	105/124 (84.7)	11/66 (16.7)
RDS, no (%)	19/124 (15.3)	55/66 (83.3)	0.000
Respiratory support days, median (IQR), days	3 (2–4)	6 (4–8)	0.000
Hospital stays, median (IQR), days	7(6–8)	10 (8–12)	0.000

SD: standard deviation; IQR: interquartile range; CPAP: continuous positive airway pressure; PPV: positive pressure ventilation; SpO₂: saturation of partial pressure oxygen; FiO₂: fraction of inspired oxygen; CO₂:carbon dioxide; HHFNC: humidified high flow nasal cannula; NPPV: non‐invasive positive pressure ventilation; TTN: transient tachypnea of the newborn; RDS: respiratory distress syndrome; MV: mechanical ventilation

Table 3. Multiple logistic analysis of adverse outcomes in outborn neonates with respiratory distress

Clinical characteristics	Unadjusted OR (95%)	P-value	Adjusted OR	P
Male	2.8 (1.4–5.3)	0.002	2.9 (1.1–7.7)	0.032
Initial FiO₂ >30	9.3 (4.3–20.1	0.000	4.8 (1.5–15.3)	0.008
Respiratory distress syndrome	27.6 (12.3–62.2)	0.000	10.4 (3.872–27.832)	0.000

Table 4. Clinical data grouped according to the time of NIV initiation (3 h) in mild or moderate-to-severe respiratory distress

	Mild RD (n = 145)			Moderate-to-severe RD (n = 45)
	NIV initiated < 3 h (n = 55 )	NIV initiated ≥ 3 h (n = 90)	P-value	NIV initiated < 3 h (n = 17 )	NIV initiated ≥ 3 h (n = 28)	P
Gestational age, median (IQR), weeks	37.9 (36.6–39.1)	37.9 (36.7–39.0)	0.787	37.6 (37.1–38.1)	37.6 (36.6–38.3)	0.725
Birth weight, median (IQR), g	3,190 (2,850–3,650)	3,280 (2,818–3,593)	0.736	3,135 (2,850–3,440)	3,175 (2,938–3,430)	0.606
Male, no (%)	34/55 (61.8)	50/90 (55.6)	0.459	9/17 (52.9)	16/28 (57.1)	0.783
Cesarean section, no (%)	38/55 (69.1)	57/90 (63.3)	0.479	14/17 (82.4)	24/28 (85.7)	1.000
Initial SpO₂, median (IQR), %	92 (87–97)	91 (85–96)	0.270	81 (70–93)	83 (75–91)	0.888
Initial FiO₂, median (IQR), %	25 (23–30)	25 (21–30)	0.525	40 (38–40)	40 (40–40)	0.944
Initial Therapy
HHFNC, no (%)	4/55 (7.3)	18/90 (20.0)		2/17 (11.8)	3/28 (10.7)
CPAP or NPPV, no (%)	51/55 (92.7)	72/90 (80.0)	0.038	15/17 (88.2)	25/28 (89.3)	1.000
Air leakage during hospitalization, no (%)	10/55 (18.2)	12/90 (13.3)	0.430	1/17 (5.9)	10/28 (35.7)	0.033
MV during hospitalization, no (%)	7/55 (12.7)	11/90 (12.2)	0.929	11/17 (64.7)	18/28 (64.3)	0.977
Respiratory support days, median (IQR), days	3 (2–4)	3 (2–4)	0.563	6 (4–7.5)	5 (3–8.8)	0.723
Hospital stays, median (IQR), days	8 (6–9)	7 (5–9)	0.654	9 (7–13)	9.5(8–12)	0.653

RD: respiratory distress; NIV: non-invasive ventilation; SpO₂: saturation of partial pressure oxygen; FiO₂: fraction of inspired oxygen; HHFNC: humidified high flow nasal cannula; CPAP: continuous positive airway pressure; NPPV: non‐invasive positive pressure ventilation; MV: mechanical ventilation

supplementaltablesEurJpediatrics.pdf

Impact of Delayed Initiation of Non-Invasive Ventilation for Respiratory Distress in Outborn Late-Preterm and Term Neonates

Status:

Version 1

Abstract

Figures

What Is Known

Introduction

Methods

Results

Discussion

Declarations

List Of Abbreviations

References

Tables

Supplementary Files

Status:

Version 1